Literature DB >> 2967195

Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.

W H Matta1, I Stabile, R W Shaw, S Campbell.   

Abstract

Uterine arterial blood FVWs were studied by doppler ultrasound in eight patients with large uterine fibroids who were treated with the GnRH agonist Buserelin intranasally for 4 months. At the end of treatment, reductions in the uterine and discrete fibroid volumes were associated with significant increases in the mean RI values for the uterine (P less than 0.01) and fibroid (P less than 0.001) vasculature, thus indicating reduction in blood flow.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2967195     DOI： 10.1016/s0015-0282(16)59966-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  Basic principles and clinical applications of the transvaginal Doppler duplex system in reproductive medicine.

Authors:  I Thaler; D Manor; J Brandes; S Rottem; J Itskovitz
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-04

3.  Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.

Authors:  Kazuya Makita; Ken Ishitani; Hiroaki Ohta; Fumi Horiguchi; Shiro Nozawa
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

4.  Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries.

Authors:  C Y Spong; R Sinow; R Renslo; E Cabus; J Rutgers; O A Kletzky
Journal:  J Assist Reprod Genet       Date:  1995-05       Impact factor: 3.412

Review 5.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.

Authors:  Reshef Tal; James H Segars
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

Review 6.  Clinical uses of gonadotropin-releasing hormone analogues.

Authors:  R F Casper
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

Review 7.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

8.  The use of transcatheter embolisation to treat uterine fibroids.

Authors:  P K Ellis; I M Kelly; P P Fogarty
Journal:  Ulster Med J       Date:  1998-11

9.  Shrinkage of uterine fibroids by preoperative LHRH analogue injection.

Authors:  H R McClelland; A J Quinn
Journal:  Ulster Med J       Date:  1992-04

10.  Differentiation of myomas by means of biomagnetic and doppler findings.

Authors:  Panagiotis Anastasiadis; Achilleas N Anastasiadis; Athanasia Kotini; Nikoleta Koutlaki; Photios Anninos
Journal:  Biomagn Res Technol       Date:  2006-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.